Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Yu Xuan Koo, Matthew Tay, Yii Ean Teh, David Teng, Daniel S. W. Tan, Iain B. H. Tan, David W. M. Tai, Richard Quek, Miriam Tao, Soon Thye LimТом:
90
Мова:
english
Сторінки:
5
DOI:
10.1007/s00277-011-1241-0
Date:
October, 2011
Файл:
PDF, 92 KB
english, 2011